A detailed history of Voloridge Investment Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 618,206 shares of NVO stock, worth $65.1 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
618,206
Holding current value
$65.1 Million
% of portfolio
0.28%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $73.6 Million - $89.9 Million
618,206 New
618,206 $73.6 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $5.39 Million - $7.17 Million
52,788 New
52,788 $6.78 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $33.6 Million - $73.8 Million
369,806 Added 97.77%
748,057 $68 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $828,409 - $916,944
5,311 Added 1.42%
378,251 $61.2 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $8.94 Million - $10.8 Million
-67,572 Reduced 15.34%
372,940 $59.3 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $15.8 Million - $20.9 Million
154,474 Added 54.0%
440,512 $59.6 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $13.8 Million - $17 Million
145,324 Added 103.28%
286,038 $28.5 Million
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $14.5 Million - $17.1 Million
140,714 New
140,714 $15.7 Million
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $8.22 Million - $9.93 Million
-88,250 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $7.52 Million - $9.18 Million
78,409 Added 796.76%
88,250 $9.88 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $830,777 - $1.05 Million
9,841 New
9,841 $945,000
Q4 2020

Feb 16, 2021

SELL
$63.89 - $73.8 $6.26 Million - $7.23 Million
-97,987 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$63.69 - $70.22 $2.1 Million - $2.31 Million
32,964 Added 50.7%
97,987 $6.8 Million
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $3.59 Million - $4.17 Million
-61,315 Reduced 48.53%
65,023 $4.26 Million
Q1 2020

May 15, 2020

SELL
$49.46 - $64.78 $4.85 Million - $6.35 Million
-98,018 Reduced 43.69%
126,338 $7.61 Million
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $6.87 Million - $8.03 Million
137,803 Added 159.21%
224,356 $13 Million
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $2.56 Million - $2.88 Million
53,815 Added 164.38%
86,553 $4.48 Million
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $1.53 Million - $1.72 Million
32,738 New
32,738 $1.67 Million
Q4 2018

Feb 14, 2019

SELL
$41.54 - $47.25 $717,105 - $815,676
-17,263 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$46.76 - $51.24 $7.57 Million - $8.3 Million
-161,958 Reduced 90.37%
17,263 $814,000
Q2 2018

Aug 14, 2018

BUY
$44.29 - $50.42 $4.78 Million - $5.45 Million
108,005 Added 151.66%
179,221 $8.27 Million
Q1 2018

May 15, 2018

SELL
$48.49 - $58.14 $2.76 Million - $3.31 Million
-56,852 Reduced 44.39%
71,216 $3.51 Million
Q4 2017

Feb 14, 2018

BUY
$47.53 - $53.73 $6.09 Million - $6.88 Million
128,068
128,068 $6.87 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.